Initial Statement of Beneficial Ownership

Philip J. Vickers, a director at Akebia Therapeutics, Inc. (AKBA), has filed an initial statement of beneficial ownership. The filing, dated April 3, 2026, reports that Vickers has no securities directly owned. The reporting address is C/O Akebia Therapeutics, Inc., 245 First Street, Cambridge, MA 02142. This filing is a Form 3, indicating an initial statement of beneficial ownership.